Zoetis to launch Vetscan VS3 chemistry analyser across Asia in 2027
Zoetis will roll out its next-generation Vetscan VS3 point-of-care chemistry analyser in five Asian markets from early 2027. The analyser adds an in-clinic C-reactive protein (CRP) test and delivers results within minutes.
Zoetis is to bring its latest point-of-care chemistry analyser, Vetscan VS3, to veterinary practices across Asia from early 2027, broadening its in-clinic diagnostics portfolio in a region it describes as a priority.
The first phase of the rollout will cover Thailand, the Philippines, Indonesia, Singapore and Taiwan, with further markets to follow.
Building on the established VS2 chemistry platform, the VS3 offers four rotor configurations and what Zoetis calls the industry’s most comprehensive test menu. New parameters include creatine kinase, magnesium, triglycerides and C-reactive protein (CRP), the company’s first in-clinic CRP test. Using refined microfluidic technology, the analyser delivers results within minutes, reducing the need for additional devices or reference laboratory testing.
The screenless, low-maintenance design integrates directly with Vetscan Hub, linking the analyser to the wider Zoetis Diagnostics ecosystem to support ongoing patient monitoring.
Diego Garcia, President of Global Diagnostics at Zoetis, said the launch would widen access to connected point-of-care chemistry testing, backed by field support, training and education to help clinics use diagnostic information effectively.
Tinh-Son Nguyen, International Diagnostic Medical Manager, said chemistry testing was fundamental to everyday veterinary practice, from early disease detection to managing acute and chronic conditions, and that timely in-clinic access could make a meaningful difference across Asia’s diverse practice settings.
The VS3 will make its public debut at the FASAVA 2026 congress in Taiwan, running from 31 October to 2 November. Zoetis also plans to launch its AI-powered haematology analyser, Vetscan OptiCell, in the region in 2027, extending its connected diagnostics offering.
"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."